High Tide forecasts Q3 revenue of C$ 195 million-C$ 200 million, topping estimates - HITI News | RalliesHigh Tide forecasts Q3 revenue of C$ 195 million-C$ 200 million, topping estimates
H
HITI• Preliminary Q3 guidance tops analyst estimates
- High Tide issued preliminary Q3 guidance for revenue of C$ 195 million-C$ 200 million, implying 9%-12% sequential growth.
- The revenue outlook implies 30%-34% year-over-year growth, above FactSet analyst consensus of C$ 183.4 million.
- Gross profit is forecast at C$ 51 million-C$ 53.5 million, implying 5%-11% sequential growth and 27%-33% year-over-year growth.
- Adjusted EBITDA is seen at C$ 15.2 million-C$ 16.5 million, implying 9%-19% sequential growth and 43%-55% year-over-year growth.
- Remexian Pharma GmbH distributed over 10 tonnes of medical cannabis flower in the quarter, up 33% sequentially and 60% year over year.
•
